Histone Lysine Methyltransferase Wolf-Hirschhorn Syndrome Candidate 1 Is Involved in Human Carcinogenesis through Regulation of the Wnt Pathway

Jenuwein, 2001, Translating the histone code, Science, 293, 1074, 10.1126/science.1063127 Lachner, 2001, Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins, Nature, 410, 116, 10.1038/35065132 Hamamoto, 2004, SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells, Nat Cell Biol, 6, 731, 10.1038/ncb1151 Hamamoto, 2006, Enhanced SMYD3 expression is essential for the growth of breast cancer cells, Cancer Sci, 97, 113, 10.1111/j.1349-7006.2006.00146.x Volkel, 2007, The control of histone lysine methylation in epigenetic regulation, Biochimie, 89, 1, 10.1016/j.biochi.2006.07.009 Jenuwein, 1998, SET domain proteins modulate chromatin domains in eu-and heterochromatin, Cell Mol Life Sci, 54, 80, 10.1007/s000180050127 Rea, 2000, Regulation of chromatin structure by site-specific histone H3 methyltransferases, Nature, 406, 593, 10.1038/35020506 Stec, 1998, WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma, Hum Mol Genet, 7, 1071, 10.1093/hmg/7.7.1071 Nimura, 2009, A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome, Nature, 460, 287, 10.1038/nature08086 Garlisi, 2001, A unique mRNA initiated within a middle intron of WHSC1/MMSET encodes a DNA binding protein that suppresses human IL-5 transcription, Am J Respir Cell Mol Biol, 24, 90, 10.1165/ajrcmb.24.1.4224 Chesi, 1998, The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts, Blood, 92, 3025, 10.1182/blood.V92.9.3025 Brito, 2009, MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cells, Haematologica, 94, 78, 10.3324/haematol.13426 Lauring, 2008, The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity, Blood, 111, 856, 10.1182/blood-2007-05-088674 Marango, 2008, The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor, Blood, 111, 3145, 10.1182/blood-2007-06-092122 Todoerti, 2005, Transcription repression activity is associated with the type I isoform of the MMSET gene involved in t(4;14) in multiple myeloma, Br J Haematol, 131, 214, 10.1111/j.1365-2141.2005.05741.x Angrand, 2001, NSD3, a new SET domain-containing gene, maps to 8p12 and is amplified in human breast cancer cell lines, Genomics, 74, 79, 10.1006/geno.2001.6524 Kassambara, 2009, MMSET is overexpressed in cancers: link with tumor aggressiveness, Biochem Biophys Res Commun, 379, 840, 10.1016/j.bbrc.2008.12.093 Wallard, 2006, Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma, Br J Cancer, 94, 569, 10.1038/sj.bjc.6602931 Olsburgh, 2003, Uroplakin gene expression in normal human tissues and locally advanced bladder cancer, J Pathol, 199, 41, 10.1002/path.1252 Kato, 2005, A novel human tRNA-dihydrouridine synthase involved in pulmonary carcinogenesis, Cancer Res, 65, 5638, 10.1158/0008-5472.CAN-05-0600 Kikuchi, 2003, Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs, Oncogene, 22, 2192, 10.1038/sj.onc.1206288 Taniwaki, 2006, Gene expression profiles of small-cell lung cancers: molecular signatures of lung cancer, Int J Oncol, 29, 567 Ishikawa, 2004, ADAM8 as a novel serological and histochemical marker for lung cancer, Clin Cancer Res, 10, 8363, 10.1158/1078-0432.CCR-04-1436 Ishikawa, 2007, Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas, Cancer Res, 67, 11601, 10.1158/0008-5472.CAN-07-3243 Kitahara, 2001, Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia, Cancer Res, 61, 3544 Nakamura, 2004, Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection, Oncogene, 23, 2385, 10.1038/sj.onc.1207392 Cho, 2011, Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1, Neoplasia, 13, 676, 10.1593/neo.11512 Takawa, 2011, Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker, Cancer Sci, 102, 1298, 10.1111/j.1349-7006.2011.01958.x Toyokawa, 2011, Minichromosome maintenance protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancer, Mol Cancer, 10, 65, 10.1186/1476-4598-10-65 Hayami, 2011, Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers, Int J Cancer, 128, 574, 10.1002/ijc.25349 Hayami, 2010, Overexpression of the JmJC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway, Mol Cancer, 9, 59, 10.1186/1476-4598-9-59 Yoshimatsu, 2011, Dysregulation of PRMT1 and PRMT6, type I arginine methyltransferases, is involved in various types of human cancers, Int J Cancer, 128, 562, 10.1002/ijc.25366 Cho, 2011, Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells, Cancer Res, 71, 1, 10.1158/0008-5472.CAN-10-2446 Nishidate, 2004, Genome-wide gene-expression profiles of breast-cancer cells purified with laser microbeam microdissection: identification of genes associated with progression and metastasis, Int J Oncol, 25, 797 Takata, 2005, Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling, Clin Cancer Res, 11, 2625, 10.1158/1078-0432.CCR-04-1988 Buongiorno, 2008, Rac1 GTPase and the Rac1 exchange factor Tiam1 associate with Wnt-responsive promoters to enhance β-catenin/TCF-dependent transcription in colorectal cancer cells, Mol Cancer, 7, 73, 10.1186/1476-4598-7-73 Kuroda, 1998, Role of IQGAP1, a target of the small GTPases Cdc42 and Rac1, in regulation of E-cadherin-mediated cell-cell adhesion, Science, 281, 832, 10.1126/science.281.5378.832 Mazieres, 2005, Wnt signaling in lung cancer, Cancer Lett, 222, 1, 10.1016/j.canlet.2004.08.040 Minna, 2002, Focus on lung cancer, Cancer Cell, 1, 49, 10.1016/S1535-6108(02)00027-2 Thievessen, 2003, E-cadherin involved in inactivation of WNT/β-catenin signalling in urothelial carcinoma and normal urothelial cells, Br J Cancer, 88, 1932, 10.1038/sj.bjc.6601031 Urakami, 2006, Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/β-catenin signaling pathway, Clin Cancer Res, 12, 383, 10.1158/1078-0432.CCR-05-1344 Yue, 2008, Downregulation of Dkk3 activates β-catenin/TCF-4 signaling in lung cancer, Carcinogenesis, 29, 84, 10.1093/carcin/bgm267 Nishisho, 1991, Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients, Science, 253, 665, 10.1126/science.1651563 Giles, 2003, Caught up in a Wnt storm: Wnt signaling in cancer, Biochim Biophys Acta, 1653, 1 Nusse, 2005, Wnt signaling in disease and in development, Cell Res, 15, 28, 10.1038/sj.cr.7290260 Paul, 2008, Wnt signaling and cancer development: therapeutic implication, Neoplasma, 55, 165 Ohgaki, 2004, APC mutations are infrequent but present in human lung cancer, Cancer Lett, 207, 197, 10.1016/j.canlet.2003.10.020 Ueda, 2001, Mutations of the β-and .-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas, Br J Cancer, 85, 64, 10.1054/bjoc.2001.1863 Pokholok, 2005, Genome-wide map of nucleosome acetylation and methylation in yeast, Cell, 122, 517, 10.1016/j.cell.2005.06.026 Xiao, 2003, Phosphorylation of RNA polymerase II CTD regulates H3 methylation in yeast, Genes Dev, 17, 654, 10.1101/gad.1055503 Luco, 2010, Regulation of alternative splicing by histone modifications, Science, 327, 996, 10.1126/science.1184208 Cerveira, 2003, Frequency of NUP98-NSD1 fusion transcript in childhood acute myeloid leukaemia, Leukemia, 17, 2244, 10.1038/sj.leu.2403104 Wang, 2007, NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis, Nat Cell Biol, 9, 804, 10.1038/ncb1608 Kim, 2008, Multiple-myeloma-related WHSC1/MMSET isoform RE-IIBP is a histone methyltransferase with transcriptional repression activity, Mol Cell Biol, 28, 2023, 10.1128/MCB.02130-07 Li, 2009, The target of the NSD family of histone lysine methyltransferases depends on the nature of the substrate, J Biol Chem, 284, 34283, 10.1074/jbc.M109.034462 Bahmanyar, 2008, β-Catenin is a Nek2 substrate involved in centrosome separation, Genes Dev, 22, 91, 10.1101/gad.1596308 Hadjihannas, 2006, Aberrant Wnt/β-catenin signaling can induce chromosomal instability in colon cancer, Proc Natl Acad Sci USA, 103, 10747, 10.1073/pnas.0604206103 Martinez-Garcia, 2011, The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells, Blood, 117, 211, 10.1182/blood-2010-07-298349 Morishita, 2011, Cancers and the NSD family of histone lysine methyltransferases, Biochim Biophys Acta, 1816, 158 Nimura, 2011, Histone methyltransferases: regulation of transcription and contribution to human disease, J Mol Med (Berl), 88, 1213, 10.1007/s00109-010-0668-4 Pei, 2011, MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites, Nature, 470, 124, 10.1038/nature09658 Greiner, 2005, Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3–9, Nat Chem Biol, 1, 143, 10.1038/nchembio721 Kubicek, 2007, Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase, Mol Cell, 25, 473, 10.1016/j.molcel.2007.01.017